Twist Bioscience began shipping of synthetic RNA controls for Kappa (B.1.617.1) SARS-CoV-2 variants
On Jun. 8, 2021, Twist Bioscience announced that it had started shipping its synthetic RNA reference controls for…
Senolytics reduced COVID-19 symptoms in preclinical studies
On Jun. 8, 2021, Mayo Clinic researchers and colleagues at the University of Minnesota showed that COVID-19 exacerbates…
Pixel by Labcorpﾮ COVID-19 PCR test home collection kits now available nationwide
On Jun. 8, 2021, LabCorp announced that its Pixel COVID-19 PCR Test Home Collection Kits were availavle in…
FDA approved PREVNAR 20ﾙ, Pfizerﾒs pneumococcal 20-valent conjugate vaccine for adults ages 18 years or older
On Jun. 8, 2021, Pfizer announced that the U.S. Food and Drug Administration (FDA) had approved PREVNAR 20ﾙ…
INOVIO expanded partnership with Advaccine to conduct global phase 3 efficacy trial of COVID-19 DNA vaccine candidate
On Jun. 8, 2021, Inovio Pharma announced an expansion of its previously announced partnership with Advaccine Biopharmaceuticals to…
Study suggested no association between antiseizure drugs used during pregnancy and neurodevelopmental problems in children at age 2
On Jun. 7, 2021, the National Institutes of Health announced new findings published in JAMA Neurology that suggested…
MediciNova initiated sheep study under BARDA to develop MN-166 (ibudilast) as countermeasure against chlorine
On Jun. 7, 2021, MediciNova announced it had initiated a sheep study to investigate MN-166 (ibudilast) in an…
FDA granted accelerated approval for ADUHELMﾙ as the first and only Alzheimerﾒs disease treatment
On Jun. 7, 2021, Biogen and Eisai announced that the U.S. Food and Drug Administration (FDA) had granted…
Moderna filed for conditional Marketing Approval for its COVID-19 vaccine in adolescents in the EU
On Jun. 7, 2021, Moderna announced that it had submitted for a conditional marketing approval (CMA) for its…
Moderna and Medison Pharma partnered to commercialize COVID-19 vaccine in Central Eastern Europe and Israel
On Jun. 7, 2021, Moderna announced a new agreement to commercialize its COVID-19 Vaccine across Central Eastern Europe…
OraSure Technologies receives three EUA’s for its COVID-19 rapid antigen tests for non-prescription use
On Jun. 7, 2021, OraSure Technologies announced that it had received Emergency Use Authorization (EUA) from the FDA…
FDA approved new rug treatment for chronic weight management, first since 2014
On Jun. 4, 2021, the U.S. Food and Drug Administration announced it had approved Novo Nordisk’s Wegovy (semaglutide)…
FDA approved new drug treatment for chronic weight management, first since 2014
On Jun. 4, 2021, the U.S. Food and Drug Administration approved Novo Nordisk’s Wegovy (semaglutide) injection (2.4 mg…
Chimerix received U.S. FDA approval for TEMBEXAﾮ (brincidofovir) for treatment of smallpox
On Jun. 4, 2021, Chimerix announced that the U.S. Food and Drug Administration (FDA) had granted TEMBEXAﾮ (brincidofovir)…
FDA authorized lower 1,200 mg intravenous and subcutaneous dose of REGEN-COV antibody cocktail to treat COVID-19 patients
On Jun. 4, 2021, Regeneron announced the U.S. Food and Drug Administration (FDA) updated the Emergency Use Authorization…
Resverlogix and EVERSANA announced partnership to support commercialization of Apabetalone for COVID-19 in U.S. and Canada
On Jun. 3, 2021, Resverlogix announced a partnership to support planned commercialization of apabetalone in the United States,…
NIH researchers identified potential new antiviral drug for COVID-19
On Jun. 3, 2021, the National Institutes of Health announced that the experimental drug TEMPOL may be a…
Innovation Pharma completed enrollment in phase 2 clinical trial for COVID-19
On Jun. 3, 2021, Innovation Pharma announced that it had achieved full patient enrollment in its randomized, double-blind,…
Moderna announced agreement to supply the Republic of Botswana with COVID-19 vaccine
On Jun. 3, 2021, Moder’s vaccine against COVID-19, to support the government’s ongoing efforts to secure access to…
Lonza and Moderna announced collaboration for drug substance manufacturing of COVID-19 Vaccine in the Netherlands
On Jun. 2, 2021, Lonza announced the expansion of its collaboration with Moderna. The expanded collaboration extended the…
Relief Therapeutics reported that NRx Pharma, had submitted an application for EUA for Aviptadil to the U.S. FDA
On Jun. 2, 2021, RELIEF THERAPEUTICS reported that its collaboration partner, NRx Pharmaceuticals, announced that it had submitted…
UNICEF and Moderna announced long term agreement to supply vaccine on behalf of the COVAX facility
On Jun. 2, 2021, Moderna and UNICEF announced that they had signed a long-term agreement for the supply…
Vaxxas and collaborators revealed potential of Vaxxasﾒ high-density microarray patch to deliver SARS-CoV-2 vaccine
On Jun. 2, 2021, Vaxxas announced that research demonstrated the potential of Vaxxasﾒ novel high-density microarray patch (HD-MAP)…
NIH launched clinical trial of universal influenza vaccine candidate
On Jun. 1, 2021, the National Institutes of Health (NIH) announced the first-in-human, Phase 1 trial assessing the…
Scientists discovered a new genetic form of ALS in children
On Jun. 1, 2021, in a study of 11 medical-mystery patients, an international team of researchers led by…
Sanofi and Parkinson’s Foundation collaborated to advance availability of free genetic testing and counseling for people with Parkinson’s disease
On Jun. 1, 2021, Sanofi announced that Vaxelis (Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus…
U.S. blood donations declared safe under current COVID-19 screening guidelines
On Jun. 1, 2021, a study by researchers at the National Institutes of Health and their colleagues found…
WHO validated Sinovac COVID-19 vaccine for emergency use
On Jun. 1, 2021, WHO validated the Sinovac-CoronaVac COVID-19 vaccine for emergency use, giving countries, funders, procuring agencies…
WHO $50 billion health, trade and finance roadmap to end the pandemic and secure a global recovery
On Jun. 1, 2021, the heads of the world’s predominant global financing, health and trade agencies united to…
NIH clinical trial evaluating mixed COVID-19 vaccine schedules began
On Jun. 1, 2021, the National Institutes of Health announced that it had started a Phase 1/2 clinical…